Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol.
Saved in:
| Title: | Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol. |
|---|---|
| Authors: | Andel D; Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, PO BOX 85500, 3508 GA, Utrecht, The Netherlands. D.S.H.Andel-3@umcutrecht.nl., Lam MGEH; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Cancer Center, Utrecht, The Netherlands., de Bruijne J; Department Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands., Smits MLJ; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Cancer Center, Utrecht, The Netherlands., Braat AJAT; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Cancer Center, Utrecht, The Netherlands., Moelker A; Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Vegt E; Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Ruiter SJS; Department of HPB & Liver Transplantation, University Medical Center Groningen, Groningen, The Netherlands., Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands., Grazi G; Hepatopancreatobiliary Surgery, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Vallati GE; Interventional Radiology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Bennink RJ; Department of Radiology and Nuclear Medicine, Cancer Center, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands., van Delden OM; Department of Radiology and Nuclear Medicine, Cancer Center, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands., Kranenburg OW; Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, PO BOX 85500, 3508 GA, Utrecht, The Netherlands., Ijzermans JNM; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Nijkamp MW; Department of HPB & Liver Transplantation, University Medical Center Groningen, Groningen, The Netherlands., Erdmann JI; Department of Surgery, Cancer Center, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Sciuto R; Nuclear Medicine, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Hagendoorn J; Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, PO BOX 85500, 3508 GA, Utrecht, The Netherlands., Borel Rinkes IHM; Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, PO BOX 85500, 3508 GA, Utrecht, The Netherlands. I.H.M.BorelRinkes@umcutrecht.nl. |
| Source: | BMC cancer [BMC Cancer] 2023 Aug 18; Vol. 23 (1), pp. 771. Date of Electronic Publication: 2023 Aug 18. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
